Australia  

Celebrating 10 Years of Trusted News Discovery
One News Page
> >

Next Science lists on ASX after raising $35 million to commercialise Xbio technology

Proactive Investors Thursday, 18 April 2019
Next Science Limited (ASX:NXS) listed on the ASX today after raising $35 million in an initial public offering (IPO) last month to commercialise its anti-bacterial proprietary technology. Founded in 2012, the Sydney-based biotech has developed products to address the problem of bacterial biofilms that can result in chronic infections. The company has received financial backing from Australian businessman Lang Walker, with Walker Entities remaining Next Science’s largest shareholder after the IPO. Four products already in market An initial suit of four products are currently in market and Next Science has a strong development pipeline with multiple applications across medical devices, over-the-counter drugs and prescription pharmaceuticals. The launch of the company’s acne treatment is expected to begin in Australia during 2019 under a five-year agreement with Advance Skin Technology Pty Ltd. A further three new applications of the Xbio technology will be launched over the next 12 months as Next Science finalises partnership negotiations with leading specialist distributors. These include sinus and middle ear washes as well as antimicrobial washout treatments for minimally invasive surgical procedures. Numerous ongoing patent applications Next Science’s products were launched following extensive research and development in the US, including in vitro and in vivo testing, multiple clinical trials, four Federal Drug Administration clearances and more than 70,000 patient episodes of care to date. The company owns 100% of the intellectual property relating to its Xbio technology platform which is currently protected by 15 patents and 47 patent applications. Having been already awarded specific patents in wound gel, acne cream, oral rinse and post-surgical disinfection, Next Science has patents under review for acne infections, keloid abatement and minimum ciliotoxicity for use in sinuses and the middle ear.  
0
shares
ShareTweetSavePostSend
 
Credit: Reuters - 3D Animations (Next Me - Published < > Embed
News video: Scientists create world's first 3D-printed heart

Scientists create world's first 3D-printed heart 00:49

Researchers at Tel Aviv University have produced a heart using 3D printing technology and human tissue, according to a study published in the journal Advanced Science.

Recent related videos from verified sources

Trump Administration Proposal May Take Away Free Lunch For Some Students [Video]Trump Administration Proposal May Take Away Free Lunch For Some Students

The Trump administration recently made a proposal to reduce the number of people who get food stamps. According to the Huffington Post, this means nearly a million children could stop being eligible..

Credit: Wochit News     Duration: 00:32Published

480-Million-Year-Old Fossils Show Animals In Same Direction Likely During Storm [Video]480-Million-Year-Old Fossils Show Animals In Same Direction Likely During Storm

480-million-year-old fossils found in Morocco show a group of trilobites that arranged themselves in an orderly line.

Credit: GeoBeats     Duration: 00:41Published


Recent related news from verified sources

Rimfire Pacific completes investor-led placement to execute next phase of discovery

Rimfire Pacific Mining NL (ASX:RIM) has completed an investor-led placement, raising $500,000 to help execute the next phase of discovery at highly prospective...
Proactive Investors

SenSen Networks Ltd continues contract win momentum with Geelong council deal

SenSen Networks Ltd (ASX:SNS) has continued its positive momentum with another contract win with the Geelong City Council in Victoria. Under the three year deal,...
Proactive Investors

You Might Like

Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2019 One News Page Ltd. All Rights Reserved.
About us  |  Contact us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  In the News  |  DMCA / Content Removal  |  Privacy & Data Protection Policy
How are we doing? FeedbackSend us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter  •  FOLLOW us on Pinterest
One News® is a registered trademark of One News Page Ltd.